Related Experiment Video

Updated: Sep 30, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.8K

SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK

Xiu Shi1,2,3, Xuejiao Yu4, Juan Wang1

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Molecular Oncology
|March 12, 2022
PubMed

Insights

Salt-inducible kinase 2 (SIK2) promotes ovarian cancer cell motility, migration, and metastasis. SIK2 activates myosin light chain kinase (MYLK), which enhances cancer progression and is linked to reduced survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Salt-inducible kinase 2 (SIK2) is overexpressed in various cancers and linked to disease progression.
  • The precise mechanisms of SIK2's role in ovarian cancer cell motility, migration, and metastasis remain incompletely understood.

Purpose of the Study:

  • To elucidate the mechanisms by which SIK2 regulates ovarian cancer cell motility, migration, and metastasis.
  • To investigate the role of SIK2-mediated signaling pathways in ovarian cancer progression.

Main Methods:

  • In vitro and in vivo assays to assess ovarian cancer cell motility, migration, and metastasis.
  • Western blotting and immunoprecipitation to analyze protein phosphorylation and interactions.
  • Correlation analysis of SIK2 and MYLK-pS343 expression in ovarian cancer cell lines and patient tissues.

Main Results:

  • SIK2 overexpression significantly promotes ovarian cancer cell motility, migration, and metastasis.
  • SIK2 directly phosphorylates and activates myosin light chain kinase (MYLK) at Ser343, leading to downstream phosphorylation of myosin light chain 2 (MYL2).
  • Adipocytes enhance ovarian cancer cell motility via SIK2 and MYLK phosphorylation; SIK2 and MYLK-pS343 co-expression correlates with reduced patient survival.

Conclusions:

  • SIK2 is a key regulator of ovarian cancer cell motility, migration, and metastasis through the MYLK-MYL2 pathway.
  • SIK2 and its downstream signaling represent a potential therapeutic target for ovarian cancer treatment.
  • The interaction between SIK2, MYLK, and adipocytes highlights a complex mechanism driving ovarian cancer progression.
Keywords:
MYLKSIK2cell motilitymetastasisovarian cancerphosphorylation

More Related Videos

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.5K
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis08:54

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

Published on: February 17, 2012

14.6K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Role of Myosin in Cell Migration01:18

Role of Myosin in Cell Migration

Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II  is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
2.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K